We do not accept capital from unvetted sources. We select partners whose history and actions align with the long-term sovereignty of the human species.
We view every new capital partner as a potential vector for mission drift. To mitigate this, the Governance & Alignment Charter (GAC) acts as an independent check on all incoming funds.
The GAC operates outside the standard board structure. It possess absolute veto power over any investment term sheet that threatens long-term safety constraints.
It is not enough to have funds. Before we accept a single dollar, we initiate a rigorous "speculation" audit of your investment team and LP base.
We review every past investment, board vote, and public statement to build a behavioral profile of your firm. We look for patterns of forced acceleration.
We determine the true driver of your interest. We filter specifically for "Patient Capital"—partners willing to endure decades of R&D without liquidity pressure.
Final candidacy must be ratified by the Governance & Alignment Charter (GAC). This Charter holds absolute veto power over the Board regarding capital injection.
We utilize open-source intelligence to verify the true origin of your capital. Connections to misaligned state actors or predatory conglomerates result in immediate disqualification.
The entity demonstrates a historical pattern of REDACTED DATA BLOCK focused on short-term liquidity events. Analysis of board minutes (2022-2024) indicates a preference for aggressive accelerationism over established safety constraints.
Primary capital source traced to REDACTED SOURCE ID with confirmed affiliation to adversarial state actors. This constitutes a Category 1 Violation of the Blankline Sovereignty Protocol.
The Governance & Alignment Charter (GAC) hereby exercises its veto power. No term sheet shall be issued. This decision is absolute and not subject to appeal.
Fig 1. Sample Rejection Dossier (Redacted)
If you believe your firm can withstand the GAC's scrutiny, proceed to the candidacy docket.